Autoimmune Diseases  >>  nerispirdine (HP184)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
nerispirdine (HP184) / Sanofi
NCT00772525: Single Oral Doses Study of Nerispirdine on Visual Function in Patients With Multiple Sclerosis

Completed
2
31
US
Nerispirdine, HP184, Placebo
Sanofi
Multiple Sclerosis, Optic Nerve, Neuritis
06/09
06/09
NCT00811902 / 2008-001999-67: Efficacy, Safety, and Tolerability of Nerispirdine in Patients With Multiple Sclerosis

Completed
2
405
US, Canada, Europe
Nerispirdine, HP184, placebo
Sanofi
Multiple Sclerosis
03/10
03/10

Download Options